China Summit Preview: The Bridge to Innovation

BeiGene’s Xiaobin Wu, Zai Lab’s Billy Cho on company priorities, finding talent and future bellwethers among China’s innovators

BeiGene’s Xiaobin Wu and Zai Lab’s Billy Cho join the BioCentury team to preview some of the key themes of next week’s China Healthcare Summit. On a special edition of the BioCentury This Week podcast, Wu and Cho discuss their companies’ plans for global expansion, what it will take to build China’s next bellwethers, and the scramble for talent to fill top roles at China’s burgeoning class of innovators.

Wu is president, COO and GM, China of BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) and the former head of China for Pfizer Inc. (NYSE:PFE). Cho is CFO of Zai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688) and former head of Asia healthcare investment banking for Citi. The 8th annual China Healthcare Summit is a hybrid event presented by BioCentury and BayHelix that runs from Nov. 16 to 19. Registration is still open.